Abstract:Dear Editors, A 25-year-old woman was referred to our department in June 2020 due to a 1-month history of severe epidermolysis (Figure 1a). Of note, she had been diagnosed with systemic lupus erythematosus (SLE) in 2012 due to arthralgia, elevated levels of double-stranded DNA (dsDNA >800 IU) and antinuclear antibody titer (ANA >1 : 320). Oral methylprednisolone and cyclophosphamide (CTX) were given. Further examination revealed a large abdominal mass with benign pathology (17 cm x 10 cm, SUV = 2.9). Surgery was not performed after weighing the risks of surgery against the rather benign biological behavior of the tumor. However, in February 2020, she developed a highly vascular extra-axial tumor. The postoperative pathology of the cranial lesion confirmed the diagnosis of solitary fibrous tumor (SFT). Two months later, she suffered full-body blistering and epidermolysis (Nikolsky's sign positive), severe oral and genital erosions, and fever. Laboratory tests showed elevated anti-desmoglein (Dsg) 1 (161.8 IU/ml), Dsg3 (110.2 IU/ml), and positive envoplakin, while anti-bullous pemphigoid (BP) 180 and BP 230 were negative. Indirect immunofluorescence (IIF) on rat bladder (Figure 1c) showed a weak positive result of scattered intracellular staining. Skin tissue pathology demonstrated acantholysis above the basal layer (Figure 1d). All of the above features strongly supported a diagnosis of paraneoplastic pemphigus (PNP). After 2 months of tailored treatment with glucocorticoids (GC) and other supportive therapies, PNP activity was controlled with no new blisters or erythema (Figure 1b). Unfortunately, re-evaluation of the tumor revealed multiple metastases (brain, lung, liver, bone, lymph nodes, and other sites) (Figure 2a). Histopathology and immunohistochemistry of mass biopsy showed atypical spindle-shaped tumor cells over a hypercellular infiltration area (hematoxylin and eosin stain), as well as positive STAT-6 and Ki-67 immunohistochemical staining in spindle-shaped cells (Figure 2b–d), further confirming the diagnosis of atypical malignant SFT with multiple metastases. After an informed multidisciplinary team (MDT) discussion, surgery, intervention, or targeted therapy were not recommended due to the potential high risks. The patient's condition worsened with SFT exacerbation and PNP relapse over the next year, and she died in April 2021. Previous studies have shown that SFT can be associated with paraneoplastic syndromes, the most common of which are non-islet hypoglycemia and hypertrophic pulmonary osteoarthropathy.1 To date, the only report of an autoimmune disease associated with SFT was a 74-year-old Japanese woman diagnosed with SFT and autoimmune hemolytic anemia (AIHA).2 Her AIHA improved significantly after resection of the SFT, suggesting a substantial association between SFT and autoimmune disease. It has been noted that PNP may be associated with various malignant tumors, but the underlying mechanism remains unclear. The most accepted theory is that the neoplasm may induce an autoimmune disease in which humoral and cell-mediated immunity contribute significantly to the development of PNP. Case-by-case variance of autoantibody profiles against Dsg, desmocollin (Dsc), alpha-2-macroglobulin-like-1 (A2ML1), and the plakin family can be observed in PNP, but their pathogenicity remains obscure.3 Anti-tumor immune dysregulation and epitope spreading may contribute to antibody production. Autoreactive T cells mediate cytotoxicity in clinical histopathology and in vivo experiments.4 Thus, the etiopathology of PNP can be broadly summarized as molecular mimicry, the breakdown of central and peripheral tolerance.5 In our case, craniotomy-induced antigen exposure could be a possible explanation for the onset of PNP. Excision of the cranial lesion could lead to epitope spreading or increased antigen expression. Solitary fibrous tumor is usually a rare but indolent tumor of mesenchymal origin. Treatment of SFT is highly variable depending on tumor location, tumor behavior, patient health status, etc. Nevertheless, several case series have advocated surgical treatment as the first choice for resectable SFT.6-10 Complete resection is a predictive factor for good prognosis.6, 8 In this patient's case, recurrent tumor, size ≥ 15 cm, tumor necrosis, hypercellularity, etc. were all risky features associated with malignant SFT behavior. Her poor physical condition due to severe infection and malnutrition further complicated tumor treatment, let alone PNP management. We herein reported a young woman suffering from abdominal SFT with atypical metastases, concomitant with PNP. To our knowledge, this is the first case of metastatic SFT with PNP. Our findings indicate that SFT might lead to paraneoplastic autoimmune diseases like PNP through tumor-related immune abnormality or surgery-induced antigen exposure. Early diagnosis and complete resection are key factors in preventing SFT deterioration and auto-immune reactions. Unfortunately, the current method for treating multiple metastases of SFT is very limited, and the patient's uncontrolled tumor at the end stage led to disease progression. We appreciate Changhai Hospital for providing histopathology and immunohistochemistry of abdominal mass biopsy results. The patient in this manuscript had given written informed consent to publication of her case details during hospitalization. Dr. Meng Pan reports grants from the National Natural Science Foundation of China (81730085 and 82173407), during the conduct of the study. None.

TIF1-γ Positive Dermatomyositis with Spontaneous Muscular Hematoma in the Context of Ovarian Cancer: A Novel Survival Case Report

The Potential Role of 18F-FDG PET/CT in Dermatomyositis with Cardiac Involvement: A Case Report

Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature

Metastatic Ovarian Tumor from Pancreatic Cancer Treated with Combined Immunotherapy: A Case Report

Tumor induced osteomalacia complicated with deep vein thrombosis and pulmonary embolism: report of two cases and literature review

Eleven cases of dermatomyositis accompanied with gynecological malignant tumor: clinical characteristics and short-term follow-up

A Rare Case of Anti-TIF-1γ Antibody Positive Dermatomyositis in Adulthood

Spontaneous Intramuscular Hemorrhage in Anti-MDA5 Positive Dermatomyositis: A Case Series and Literature Review

Analysis of the Potential Link Between Dermatomyositis and Cancer

Clinical and laboratory features between anti‐TIF1γ dermatomyositis with and without malignancy: 37 case series and a review

Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence

A rare case of severe myositis as paraneoplastic syndrome on breast cancer

Small cell lung cancer with dermatomyositis: a case report

A Rare Case of Anti-Mi-2 Antibody-Positive Dermatomyositis Associated With Gastrointestinal Stromal Tumor

Pyoderma Gangrenosum As the Initial Manifestation of Small Cell Lung Cancer with Dermatomyositis

Dermatomyositis Associated With High-Grade B-Lymphoproliferative Disorders: A Case Report and Literature Review

From Mass to Epidermolysis: a Rare Case of Multiple Metastatic Solitary Fibrous Tumor with Paraneoplastic Pemphigus

Severe onset of inflammatory myositis in a child: think to paraneoplastic myositis

Successful treatment of Anti-melanoma differentiation-associated gene 5 (MDA-5) antibody-positive dermatomyositis with rapidly progressive interstitial lung disease complicated by bilateral breast cancer following the additional tofacitinib: A case report

Clinicopathological Characteristics of Gastric Cancer Patients with Dermatomyositis and Analysis of Perioperative Management: a Case Series Study

Clinical significance of serum levels of anti-transcriptional intermediary factor 1-γ antibody in patients with dermatomyositis